Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational study. (2023)
Attributed to:
ISARIC - Coronavirus Clinical Characterisation Consortium (ISARIC-4C)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jcrc.2023.154318
PubMed Identifier: 37167775
Publication URI: http://europepmc.org/abstract/MED/37167775
Type: Journal Article/Review
Volume: 77
Parent Publication: Journal of critical care
ISSN: 0883-9441